Placeholder Banner

BIO Supporting Oxitec’s Experimental Use Permit (EUP) for Biotech Mosquito

September 30, 2021

The Biotechnology Innovation Organization (BIO) submits these comments in response to the U.S. Environmental Protection Agency’s (EPA) request for public input on the receipt of an application, 93167-EUP-2, from Oxitec Ltd requesting to amend and extend of an experimental use permit (EUP) for the OX5034 Aedes aegypti mosquitoes expressing tetracycline Trans-Activator Variant protein. The mosquitoes are proposed to be released in Florida and California to evaluate the efficacy of the mosquitoes as a tool for suppression of wild Aedes aegypti mosquito populations. The release would be an amendment and extension of an EUP authorized in April 2020.

Download Full Comments Below
BIO comments on Oxitec EUP
Discover More
The undersigned organizations and institutions, representing hundreds of thousands of individuals and entities working in science, technology, engineering, medicine, and mathematics would like to call your attention to the recent reintroduction of…
The Biotechnology Innovation Organization (BIO) is pleased to submit a statement for the record to the United States House of Representatives Committee on Agriculture Subcommittee on Commodity Exchanges, Energy, and Credit hearing on A Look at the…
We write to express our support for the nomination of Robert Bonnie to serve as the U.S. Department of Agriculture’s Under Secretary for Farm Production and Conservation. The Under Secretary position is critical in overseeing the administration of a…